Trial record 1 of 1 for:    PTC299 breast
Previous Study | Return to List | Next Study

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00508586
Recruitment Status : Completed
First Posted : July 30, 2007
Last Update Posted : March 3, 2016
United States Department of Defense
Information provided by (Responsible Party):
PTC Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2012
  Actual Study Completion Date : March 2012